Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.670
-0.910 (-19.87%)
At close: Mar 4, 2026, 4:00 PM EST
3.700
+0.030 (0.82%)
After-hours: Mar 4, 2026, 5:50 PM EST

CPIX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.4417.9618.3219.7627.04
Cash & Short-Term Investments
11.4417.9618.3219.7627.04
Cash Growth
-36.29%-1.95%-7.27%-26.93%9.24%
Accounts Receivable
16.9411.79.7613.166.88
Inventory
6.2344.619.868.43
Other Current Assets
2.452.793.033.083.34
Total Current Assets
37.0636.4535.7145.8745.69
Net Property, Plant & Equipment
8.616.457.045.51.47
Other Intangible Assets
14.0317.9722.6130.5923.95
Goodwill
0.910.910.910.910.88
Long-Term Investments
3.99----
Other Long-Term Assets
12.2313.7915.510.0512.47
Total Assets
76.8275.5881.7892.9384.46
Accounts Payable
18.5713.9114.0410.829.64
Current Portion of Long-Term Debt
-5.1---
Current Portion of Leases
0.470.360.350.170.97
Other Current Liabilities
17.7112.2513.617.598.67
Total Current Liabilities
36.7431.6227.9828.5819.28
Long-Term Debt
5.2410.1812.7816.215
Long-Term Leases
4.474.945.34.590.09
Other Long-Term Liabilities
5.826.36.457.597.49
Total Long-Term Liabilities
15.5321.4224.5328.3722.58
Total Liabilities
52.2853.0452.5256.9541.86
Common Stock
51.6846.8247.0947.4748.45
Retained Earnings
-26.8-23.97-17.49-11.21-5.64
Total Common Shareholders' Equity
24.8822.8529.636.2742.81
Minority Interest
-0.34-0.31-0.34-0.29-0.21
Shareholders' Equity
24.5422.5529.2635.9742.6
Total Liabilities & Equity
76.8275.5881.7892.9384.46
Total Debt
10.1820.5718.4320.9616.06
Net Cash (Debt)
1.26-2.61-0.11-1.210.98
Net Cash Growth
----43.03%
Net Cash Per Share
0.09-0.19-0.01-0.080.74
Book Value
24.8822.8529.636.2742.81
Book Value Per Share
1.671.632.072.492.87
Tangible Book Value
9.943.976.084.7617.98
Tangible Book Value Per Share
0.670.280.430.331.21
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q